[HTML][HTML] Near-infrared photoimmunotherapy for oropharyngeal cancer
D Nishikawa, H Suzuki, S Beppu, H Terada, M Sawabe… - Cancers, 2022 - mdpi.com
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) represents a potential novel
treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is …
treatment modality for a range of cancer types, including head and neck cancers. NIR-PIT is …
Near-infrared photoimmunotherapy of cancer: A new approach that kills cancer cells and enhances anti-cancer host immunity
H Kobayashi, A Furusawa, A Rosenberg… - International …, 2021 - academic.oup.com
Near-infrared photoimmunotherapy (NIR-PIT) is a recently developed hybrid cancer therapy
that directly kills cancer cells as well as producing a therapeutic host immune response …
that directly kills cancer cells as well as producing a therapeutic host immune response …
[HTML][HTML] Near infrared photoimmunotherapy for cancers: A translational perspective
Y Maruoka, H Wakiyama, PL Choyke, H Kobayashi - EBioMedicine, 2021 - thelancet.com
Near-infrared photoimmunotherapy (NIR-PIT) is a newly-developed, highly-selective cancer
treatment, which utilizes a monoclonal antibody conjugated to a photoabsorbing dye …
treatment, which utilizes a monoclonal antibody conjugated to a photoabsorbing dye …
[HTML][HTML] Review of RM-1929 near-infrared photoimmunotherapy clinical efficacy for unresectable and/or recurrent head and neck squamous cell carcinoma
NL Miyazaki, A Furusawa, PL Choyke, H Kobayashi - Cancers, 2023 - mdpi.com
Simple Summary RM-1929 near-infrared photoimmunotherapy (NIR-PIT) is an emerging
treatment that is currently being investigated under a world-wide Phase III clinical trial and …
treatment that is currently being investigated under a world-wide Phase III clinical trial and …
Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model
R Okada, A Furusawa, F Inagaki, H Wakiyama… - Cancer …, 2021 - Wiley Online Library
Near‐infrared photoimmunotherapy (NIR‐PIT) is a cell selective cancer therapy that uses an
antibody‐photoabsorber (IRDye700DX, IR700) conjugate (APC) and NIR light. NIR‐PIT …
antibody‐photoabsorber (IRDye700DX, IR700) conjugate (APC) and NIR light. NIR‐PIT …
[HTML][HTML] Near-infrared photoimmunotherapy (NIR-PIT) in urologic cancers
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a novel molecularly-
targeted therapy that induces rapid cancer cell death by systemically administering an …
targeted therapy that induces rapid cancer cell death by systemically administering an …
[HTML][HTML] Near infrared photoimmunotherapy; a review of targets for cancer therapy
T Kato, H Wakiyama, A Furusawa, PL Choyke… - Cancers, 2021 - mdpi.com
Simple Summary Near-infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer
treatment that uses an antibody-photoabsorber (IRDye700DX) conjugate (APC) that is …
treatment that uses an antibody-photoabsorber (IRDye700DX) conjugate (APC) that is …
Simultaneously combined cancer cell-and CTLA4-targeted NIR-PIT causes a synergistic treatment effect in syngeneic mouse models
T Kato, R Okada, A Furusawa, F Inagaki… - Molecular cancer …, 2021 - AACR
Near-infrared photoimmunotherapy (NIR-PIT) is a new cancer treatment that utilizes
antibody–IRDye700DX (IR700) conjugates. The clinical use of NIR-PIT has recently been …
antibody–IRDye700DX (IR700) conjugates. The clinical use of NIR-PIT has recently been …
[HTML][HTML] Near-infrared photoimmunotherapy for thoracic cancers: A translational perspective
K Matsuoka, M Yamada, M Sato, K Sato - Biomedicines, 2022 - mdpi.com
The conventional treatment of thoracic tumors includes surgery, anticancer drugs, radiation,
and cancer immunotherapy. Light therapy for thoracic tumors has long been used as an …
and cancer immunotherapy. Light therapy for thoracic tumors has long been used as an …
[HTML][HTML] Photoimmunotherapy for managing recurrent laryngeal cancer cervical lesions: a case report
I Okamoto, T Okada, K Tokashiki… - Case Reports in …, 2022 - karger.com
Photoimmunotherapy (PIT) targets and destroys tumor cells through irradiation with 690-nm
red light after the administration of cetuximab sarotalocan sodium, which contains …
red light after the administration of cetuximab sarotalocan sodium, which contains …